TP53 and diabetes mellitus: Excessive and sustained p53 activation, due to overexpression of mutant p53 or loss of the ubiquitin ligase ARF-bp, results in diabetes [7–9], whereas inhibition of p53 activity improves insulin sensitivity in diabetic mice [10].